Search Results - "Elisabetta Bignamini"
-
1
SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020
Published in PloS one (13-05-2021)“…To describe the symptoms and clinical course of SARS-CoV-2 infection in patients with cystic fibrosis (CF). We carried out a prospective multicentre cohort…”
Get full text
Journal Article -
2
CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis
Published in Cells (Basel, Switzerland) (06-04-2022)“…Cystic Fibrosis (CF) is an autosomal recessive disease caused by mutations in the gene encoding for the Cystic Fibrosis Transmembrane conductance Regulator…”
Get full text
Journal Article -
3
Italian pediatric respiratory society recommendations on pediatric pulmonary function testing during COVID-19 pandemic
Published in Italian journal of pediatrics (24-05-2020)“…Effective prevention and control strategies are mandatory to prevent SARS-CoV-2 infection. The Italian Pediatric Respiratory Society promotes a series of new…”
Get full text
Journal Article -
4
Do not forget asthma comorbidities in pediatric severe asthma
Published in Frontiers in pediatrics (29-07-2022)“…Asthma is the most common chronic respiratory disease in childhood. The long-term goals in managing asthma aim to control symptoms and prevent exacerbations,…”
Get full text
Journal Article -
5
Ceftolozane/Tazobactam for Treating Children With Exacerbations of Cystic Fibrosis Due to Pseudomonas aeruginosa : A Review of Available Data
Published in Frontiers in pediatrics (05-05-2020)“…Ceftolozane-tazobactam is a novel fifth-generation cephalosporin/β-lactamase inhibitor combination recently approved for treatment of both complicated…”
Get full text
Journal Article -
6
Long Term Non-invasive Ventilation in Children With Central Hypoventilation
Published in Frontiers in pediatrics (19-06-2020)“…Central hypoventilation (CH) is a quite rare disorder caused by some congenital or acquired conditions. It is featured by increased arterial concentration of…”
Get full text
Journal Article -
7
Reference values of Forced Expiratory Volumes and pulmonary flows in 3-6 year children: a cross-sectional study
Published in Respiratory research (22-02-2007)“…The aims of this study were to verify the feasibility of respiratory function tests and to assess their validity in the diagnosis of respiratory disorders in…”
Get full text
Journal Article -
8
Letter to editor
Published in Patient education and counseling (01-11-2018)Get full text
Journal Article -
9
Letter to editor
Published in Patient education and counseling (01-11-2018)Get full text
Journal Article -
10
Effects of CFTR modulator therapies on liver stiffness and bile flow: A single-centre experience
Published in Journal of hepatology (01-08-2023)Get full text
Journal Article -
11
Cardiopulmonary exercise testing in children six months after COVID‐19
Published in Pediatric pulmonology (01-07-2023)Get full text
Journal Article -
12
Elexacaftor/tezacaftor/ivacaftor in children aged 6–11 years with cystic fibrosis, at least one F508DEL allele, and advanced lung disease: A 24‐week observational study
Published in Pediatric pulmonology (01-09-2022)“…It has been shown that elexacaftor/tezacaftor/ivacaftor (ETI) cystic fibrosis transmembrane conductance regulator (CFTR) modulatory treatment is safe and…”
Get full text
Journal Article -
13
Letter to editor
Published in Patient education and counseling (01-11-2018)Get full text
Journal Article -
14
Letter to editor
Published in Patient education and counseling (01-11-2018)Get full text
Journal Article -
15
Limitations of the apnea-hypopnea index in children and young adults with neuromuscular disorders
Published in Neuromuscular disorders : NMD (01-06-2023)“…•There are no validated parameters for noninvasive ventilation initiation in children with neuromuscular disease.•Apnea-hypopnea indexes of 5 or 10 events/hour…”
Get full text
Journal Article -
16
Survival of patients with spinal muscular atrophy type 1
Published in Pediatrics (Evanston) (01-05-2013)“…Spinal muscular atrophy type 1 (SMA1) is a progressive disease and is usually fatal in the first year of life. A retrospective chart review was performed of…”
Get full text
Journal Article -
17
ERS statement on paediatric long-term noninvasive respiratory support
Published in The European respiratory journal (01-06-2022)“…Copyright © The authors 2022. Long-term noninvasive respiratory support, comprising continuous positive airway pressure (CPAP) and noninvasive ventilation…”
Get full text
Journal Article -
18
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society
Published in Infection (01-06-2022)“…Purpose To describe the clinical course of COVID-19 in patients with cystic fibrosis (CF) and to identify risk factors for severe COVID-19. Methods We…”
Get full text
Journal Article -
19
Barriers and incentives for Italian paediatricians to become smoking cessation promoters: a GARD-Italy Demonstration Project
Published in Journal of thoracic disease (01-11-2020)“…Paediatricians rarely devote any time to screening and treatment for parental tobacco use. The present project is part of a Global Alliance against Chronic…”
Get full text
Journal Article -
20
May the new suggested lower borderline limit of sweat chloride impact the diagnostic process for cystic fibrosis?
Published in The Journal of pediatrics (01-03-2018)Get full text
Journal Article